BFS
UTMD icon

Bare Financial Services’s Utah Medical Products UTMD Stock Holding History

Bare Financial Services’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.24K Sell
18
-8
-31% -$532 ﹤0.01% 1291
2026
Q1 		$1.61K Buy
26
+8
+44% +$504 ﹤0.01% 1051
2025
Q4 		$1.01K Buy
18
+10
+125% +$580 ﹤0.01% 1138
2025
Q3 		$504 Buy
+8
New +$473 ﹤0.01% 1284

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $158M AUM 42.05% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bare Financial Services's UTMD Position: Q2 2026 in Review

Bare Financial Services reduced its Utah Medical Products (UTMD) stake by 31% in Q2 2026, selling an estimated $532 and leaving 18 shares worth $1.24K. The position accounts for ﹤0.01% of the portfolio, ranked #1291.

Bare Financial Services first reported a position in UTMD in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.61K in Q1 2026. 114 funds tracked by Wall St. Rank hold UTMD as of Q2 2026.

  • Bare Financial Services held 18 shares of Utah Medical Products worth $1.24K as of Q2 2026.
  • Bare Financial Services sold 8 Utah Medical Products shares in Q2 2026, an estimated $532.
  • Utah Medical Products made up ﹤0.01% of Bare Financial Services's portfolio in Q2 2026, its #1291 holding.
  • Bare Financial Services first reported a position in Utah Medical Products in Q3 2025 and has held it in 4 quarters since.
  • Bare Financial Services's Utah Medical Products position peaked at $1.61K in Q1 2026.
  • 114 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2026.

Based on Bare Financial Services's 13F filing for Q2 2026, filed 27 Jul 2026.